70 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
This paper introduces and validates an easily implemented ordinal logistic regression method for covariate adjustment in win ratio analyses of hierarchical outcomes, demonstrating that adjusting for prognostic variables consistently improves statistical power without compromising efficiency.
This systematic review and meta-analysis indicates that low-dose colchicine reduces major adverse cardiovascular events in patients with established atherosclerotic cardiovascular disease, though substantial heterogeneity driven by timing of initiation and cumulative dose suggests that clinical benefits vary significantly across settings, with acute-phase treatment showing no benefit compared to sub-acute or chronic administration.
This paper outlines the rationale, design, and protocol for the PREG-HEART study, a patient-driven digital cohort initiative aimed at establishing a large-scale platform to investigate the epidemiology, natural history, and optimal management of cardiovascular disease in pregnancy through direct-to-patient recruitment, national health record linkage, and future clinical trials.
This study develops superior longitudinal machine learning models that outperform traditional clinical scores in predicting six major adverse clinical endpoints for atrial fibrillation patients within a Portuguese primary care cohort, while also identifying key risk determinants and introducing a prototype decision-support tool.
This study evaluates the performance of deep neural networks and heuristic-based algorithms on single-lead wearable ECG data from children, finding that optimized heuristic models achieve comparable accuracy to complex deep learning approaches, making them highly suitable for efficient real-time digital health monitoring.
This study demonstrates that explainable advanced electrocardiography (A-ECG) heart age exhibits excellent within-session and good between-session reproducibility in healthy young adults, supporting its reliability for cardiovascular risk communication.
This systematic review and meta-analysis of 14 trials involving 18,558 patients indicates that while GLP-1 receptor agonists significantly improve quality of life, functional capacity, and all-cause mortality in heart failure patients (particularly those with HFpEF and obesity), they did not significantly reduce the composite of cardiovascular death and heart failure hospitalization, with mortality benefits appearing driven by cardiovascular outcomes trial subgroups rather than dedicated heart failure trials.
This drug-target Mendelian randomization study suggests that while genetically proxied inhibition of calcium channel blockers may reduce preeclampsia risk without harming fetal growth, beta-blocker inhibition is unlikely to prevent preeclampsia and is associated with reduced birth weight primarily through direct fetal mechanisms, supporting the prioritization of calcium channel blockers for preeclampsia prevention trials.
This systematic review and meta-analysis of 59 randomized controlled trials demonstrates that SGLT2 inhibitors significantly reduce all-cause mortality and heart failure hospitalizations across the full spectrum of heart failure, supporting their role as a foundational therapy despite an increased risk of genital infections.
CARDIAC-FM is a multimodal foundation model trained on paired ECG and cardiac MRI data from the UK Biobank that achieves superior, generalizable cardiovascular risk prediction across diverse cohorts by learning joint representations, while remaining deployable in clinical settings using only ECG and standard risk scores.